Global Immuno-oncology Therapy Market By Product Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors) And By End-Users/Application (Hospitals, Ambulatory Surgical Center) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

Abstract Global Immuno-oncology Therapy Market is accounted for xx USD million in 2019 and is expected to reach xx USD million by 2026 growing at a CAGR of xx% during the forecast period. The report offers in-depth insights, revenue details, and other vital information regarding the global Immuno-oncology Therapy market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. Immuno-oncology Therapy Market report covers size, share and forecast (value and volume) by regions, top players, product types and applications, with historical data along with forecast from 2019 to 2026; The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis. By geography, this market has been segregated into five regions with revenue and growth rate of Immuno-oncology Therapy from 2013 to 2026, • North America (U.S., Canada, Mexico) • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS) • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific) • Latin America (Brazil, Rest of L.A.) • Middle East And Africa(Turkey, GCC, Rest of Middle East) The major players operating into Immuno-oncology Therapy Market include: Amgen AstraZeneca Bristol-Myers Squibb Eli-Lilly Roche GlaxoSmithKline Janssen Biotech Merck Novartis Pfizer Sanofi Spectrum Pharmaceuticals Takeda  This report segments the Global Immuno-oncology Therapy Market as follows: Global Immuno-oncology Therapy Market: Type Segment Analysis Monoclonal Antibodies Immune Checkpoint Inhibitors Immune System Modulators Cancer Vaccines Others Global Immuno-oncology Therapy Market: Application Segment Analysis Hospitals Ambulatory Surgical Center Others There are 13 chapters to put on view for Immuno-oncology Therapy Market: Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: Immuno-oncology Therapy Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis Available Customizations We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview 1.1 Immuno-oncology Therapy Market Overview 1.1.1 Immuno-oncology Therapy Product Scope 1.1.2 Market Status and Outlook 1.2 Global Immuno-oncology Therapy Market Size and Analysis by Regions (2014-2019) 1.2.1 North America Immuno-oncology Therapy Market Status and Outlook 1.2.2 EU Immuno-oncology Therapy Market Status and Outlook 1.2.3 Japan Immuno-oncology Therapy Market Status and Outlook 1.2.4 China Immuno-oncology Therapy Market Status and Outlook 1.2.5 India Immuno-oncology Therapy Market Status and Outlook 1.2.6 Southeast Asia Immuno-oncology Therapy Market Status and Outlook 1.3 Global Immuno-oncology Therapy Market Segment by Types (2014-2025) 1.3.1 Global Immuno-oncology Therapy Revenue and Growth Rate Comparison by Types (2014-2025) 1.3.2 Global Immuno-oncology Therapy Revenue Market Share by Types in 2018 1.3.3 Monoclonal Antibodies 1.3.4 Immune Checkpoint Inhibitors 1.3.5 Immune System Modulators Others 1.4 Immuno-oncology Therapy Market by End Users/Application 1.4.1 Global Immuno-oncology Therapy Revenue (USD Mn) Comparison by Applications (2014-2025) 1.4.1 Hospitals 1.4.2 Ambulatory Surgical Center 1.4.3 Others Others Chapter 2 Global Immuno-oncology Therapy Competition Analysis by Players 2.1 Global Immuno-oncology Therapy Market Size (Million USD) by Players (2014-2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter 3 Company (Top Players) Profiles and Key Data 3.1 Amgen 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Amgen, Immuno-oncology Therapy Revenue (Million USD) (2014-2019) 3.1.5 Recent Developments 3.2 AstraZeneca 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 AstraZeneca, Immuno-oncology Therapy Revenue (Million USD) (2014-2019) 3.2.5 Recent Developments 3.3 Bristol-Myers Squibb 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Bristol-Myers Squibb, Immuno-oncology Therapy Revenue (Million USD) (2014-2019) 3.3.5 Recent Developments 3.4 Eli-Lilly 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Eli-Lilly, Immuno-oncology Therapy Revenue (Million USD) (2014-2019) 3.4.5 Recent Developments 3.5 Roche 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Roche, Immuno-oncology Therapy Revenue (Million USD)(2014-2019) 3.5.5 Recent Developments 3.6 GlaxoSmithKline 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 GlaxoSmithKline, Immuno-oncology Therapy Revenue (Million USD)(2014-2019) 3.6.5 Recent Developments 3.7 Janssen Biotech 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Janssen Biotech, Immuno-oncology Therapy Revenue (Million USD)(2014-2019) 3.7.5 Recent Developments 3.8 Merck 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Merck, Immuno-oncology Therapy Revenue (Million USD) (2014-2019) 3.8.5 Recent Developments 3.9 Novartis 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Novartis, Immuno-oncology Therapy Revenue (Million USD) (2014-2019) 3.9.5 Recent Developments 3.10 Pfizer 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Pfizer, Immuno-oncology Therapy Revenue (Million USD) (2014-2019) 3.10.5 Recent Developments Chapter 4 Global Immuno-oncology Therapy Market Size Type (2014-2019) 4.1 Global Immuno-oncology Therapy Market Size by Type (2014-2019) Chapter 5 Global Immuno-oncology Therapy Market Size Application (2014-2019) 5.1 Global Immuno-oncology Therapy Market Size by Application (2014-2019) 5.2 Potential Application of Immuno-oncology Therapy in Future 5.3 Top Consumer / End Users of Immuno-oncology Therapy Chapter 6 North America Immuno-oncology Therapy Development Status and Outlook 6.1 North America Immuno-oncology Therapy Market Size (2014-2019) 6.2 North America Immuno-oncology Therapy Market Size by Application (2014-2019) Chapter 7 EU Immuno-oncology Therapy Development Status and Outlook 7.1 EU Immuno-oncology Therapy Market Size (2014-2019) 7.2 EU Immuno-oncology Therapy Market Size by Application (2014-2019) Chapter 8 Japan Immuno-oncology Therapy Development Status and Outlook 8.1 Japan Immuno-oncology Therapy Market Size (2014-2019) 8.2 Japan Immuno-oncology Therapy Market Size by Application (2014-2019) Chapter 9 China Immuno-oncology Therapy Development Status and Outlook 9.1 China Immuno-oncology Therapy Market Size and Forecast (2014-2019) 9.2 China Immuno-oncology Therapy Market Size by Application (2014-2019) Chapter 10 India Immuno-oncology Therapy Development Status and Outlook 10.1 India Immuno-oncology Therapy Market Size and Forecast (2014-2019) 10.2 India Immuno-oncology Therapy Market Size by Application (2014-2019) Chapter 11 Southeast Asia Immuno-oncology Therapy Development Status and Outlook 11.1 Southeast Asia Immuno-oncology Therapy Market Size and Forecast (2014-2019) 11.2 Southeast Asia Immuno-oncology Therapy Market Size by Application (2014-2019) Chapter 12 Market Forecast by Regions and Application (2019-2025) 12.1 Global Immuno-oncology Therapy Market Size (Million USD) by Regions (2019-2025) 12.1. North America Immuno-oncology Therapy Revenue and Growth Rate (2019-2025) 12.1.2 EU Immuno-oncology Therapy Revenue and Growth Rate (2019-2025) 12.1.3 China Immuno-oncology Therapy Revenue and Growth Rate (2019-2025) 12.1.4 Japan Immuno-oncology Therapy Revenue and Growth Rate (2019-2025) 12.1.5 Southeast Asia Immuno-oncology Therapy Revenue and Growth Rate (2019-2025) 12.1.6 India Immuno-oncology Therapy Revenue and Growth Rate (2019-2025) 12.2 Global Immuno-oncology Therapy Market Size by Application (2019-2025) Chapter 13 Immuno-oncology Therapy Market Dynamics 13.1 Immuno-oncology Therapy Market Opportunities 13.2 Immuno-oncology Therapy Challenge and Risk 13.2.1 Competition from Opponents 13.2.2 Downside Risks of Economy 13.3 Immuno-oncology Therapy Market Constraints and Threat 13.3.1 Threat from Substitute 13.3.2 Government Policy 13.3.3 Technology Risks 13.4 Immuno-oncology Therapy Market Driving Force 13.4.1 Growing Demand from Emerging Markets 13.4.2 Potential Application Chapter 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs Trend/Customer Preference 14.3 External Environmental Change 14.3.1 Economic Fluctuations 14.3.2 Other Risk Factors Chapter 15 Research Finding /Conclusion Chapter 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer 16.4 Author List
1091

1067

OUR CLIENT